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ABSTRACT
Introduction: It is well established that correct antenatal identification of small-for-gestational-
age (SGA) fetuses reduces their risk of adverse perinatal outcome with long-term consequences. 
Ultrasound estimates of fetal weight (EFWus) is the ultimate tool for this identification. It can be 
conducted as a “universal screening”, ie all pregnant women at a specific gestational age. 
However, in Denmark it is conducted as “selective screening”, ie only on clinical indication. The 
aim of this study was to assess the performance of the Danish national SGA screening program 
and the consequences of false positive and false negative SGA cases. Material and methods: In 
this retrospective cohort study, we included 2928 women with singleton pregnancies with due date 
in 2015. We defined “risk of SGA” by an EFWus ≤ -15% of expected for the gestational age and 
“SGA” as birthweight ≤ -22% of expected for gestational age. Results: At birth, the prevalence of 
SGA was 3.3%. The overall sensitivity of the Danish screening program was 62% at a false-
positive rate of 5.6%. Within the entire cohort, 63% had an EFWus as compared to 79% of the 
SGA-cases. The sensitivity was 79% for those born before 37 weeks’ gestation but only 40% for 
those born after 40 weeks’ gestation. The sensitivity was also associated to birthweight deviation; 
73% among extreme SGA cases (birthweight deviation ≤ -33%) and 55% among mild SGA 
(birthweight deviation between -22% and 27%). False diagnosis of SGA was associated with an 
increased rate of induction of labor (ORadj = 2.51, 95% CI; 1.70 to 3.71) and cesarean section 
(ORadj = 1.44, 95% CI; 0.96 to 2.18).  Conclusions: The performance of the Danish national 
screening program for SGA based on selective EFWus on clinical indication have improved 
considerably over the last 20 years. Limitations of the program are the large proportion of women 
referred to ultrasound scan and the low performance post-term. 
Keywords
Small-for-gestational-age, estimated fetal weight, ultrasound, screening, performance, outcome.
Abbreviations
SGA, small-for-gestational-age
AGA, appropriate-for-gestational-age
EFW, estimated fetal weightA
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EFWus, ultrasound-based estimation of fetal weight
BW, birthweight
GA, gestational age
FPR, false-positive rate
OR, odds ratio
ORadj, adjusted odds ratio
Key message
We assessed the performance of the Danish screening program for small-for-gestational-age 
fetuses for the first time in 20 years. Performance have improved considerably. In spite of a large 
proportion of women referred additional ultrasound, the detection of small-for-gestational-age  
babies post-term remains low.
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INTRODUCTION
It is well established that small-for-gestational-age (SGA) fetuses are at increased risk of adverse 
perinatal outcome1 and long term consequences such as metabolic syndrome2 and cardiovascular 
disease.3 Antenatal detection of SGA improves the perinatal outcome by enabling timely delivery.4 
Unfortunately, false suspicion of SGA may increase the risk of unnecessary obstetric interventions 
and thereby increases the risk of adverse neonatal outcome.5
When using ultrasound in the screening for SGA, there are two approaches; “universal ultrasound 
screening” with routine ultrasound estimation of fetal weight (EFWus) conducted in all pregnant 
women at a specific gestational age (GA) and “selective ultrasound screening” with EFWus 
conducted only on clinical indication.
Universal EFWus screening has a sensitivity of 68%-77% (birthweight (BW) ≤3rd centile) at a false 
positive rate (FPR) of 5-13% 6,7 as compared to selective EFWus screening with a sensitivity of 29-
32% at a FPR of 3%.7,8 The performance of selective ultrasound screening is highly depended on 
the clinical indications used for referral of patients to EFWus, which dictates the proportion of 
women referred for ultrasound.
In Denmark, SGA is defined by a BW below -22% of the expected for GA9 and the prevalence is 
approximately 3% among singleton pregnancies.8 The routine antenatal fetal growth assessment 
includes clinical examination and symphysis-fundal height measurements performed by midwifes 
and general practitioners every 3 to 4 weeks in pregnancy from 14 weeks’ gestation until delivery. 
Only high-risk pregnancies based on the 1st trimester risk stratification (previous obstetric or 
medical history) and complications in current pregnancy are referred to obstetric control including 
EFWus. If EFWus is ≤ -15% of the expected weight for the GA, the fetus will be considered at risk 
of SGA.10
The most recent publication on selective EFWus screening in Denmark was based on data from 
1997-98, where only 3.7% had an EFW giving a sensitivity of 29% at a FPR of 0.26%.8 However, 
based on clinical experience, the proportion of women referred for EFWus have increased 
considerably over the last decades. Therefore, the actual performance of the screening for SGA in 
Denmark is currently unknown.A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
The aim of this study was to investigate the performance of the Danish national screening program 
for SGA including selective EFWus. In addition, the obstetric consequences of false positive and 
false negative SGA cases are investigated.
MATERIAL AND METHODS
We included all 3113 women with singleton pregnancies from Aalborg University Hospital, who 
according to their nuchal translucency scan had a due date between January 1st 2015 to December 
31st 2015. The staff members were all certified by the Fetal Medicine Foundation.11 A total of 185 
women were excluded due to either abortion/miscarriage < 22 weeks of gestation or delivery 
outside North Denmark Region. Consequently, a total of 2928 women remained in this study. 
EFWus (gram) was calculated by the formula by Hadlock et.al. (based on head circumference, 
abdominal circumference and femur length)12 and EFWus deviation (%) was calculated using the 
reference curve by Maršál et.al.9
Information regarding maternal characteristics, pregnancy and delivery were obtained from 
electronic patient records (Clinical Suite™ version 18.0.4.0; DXC Technology, Tysons, VA, 
USA) and the local Fetal Medicine database (Astraia software gmbh version 1.24.10; Munich, 
Germany).
Statistical analyses
The performance of the national screening program for SGA was described by calculation of the 
sensitivity and the FPR using the binary cut-off value for expected SGA during pregnancy as 
EFWus ≤-15% and binary outcome for SGA at birth as BW ≤-22%. Logistic regression was 
performed to compare the odds ratio (OR) of obstetric and neonatal outcomes between expected 
and unexpected groups of SGA and AGA neonates. ORs were adjusted for GA at birth, BW 
deviation, maternal body mass index and parity (ORadj).
The statistical software package Stata MP version 15.0 (StataCorp LP, College Station, TX, USA) 
was used for data analysis. P-values <0.05 were considered statistically significant.A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
Ethical approval
The study was approved August 18th 2016 and additional protocol was approved August 3rd 2018 
by the Danish Patient Safety Authority, journal number 3-3013-1673/1. Data storage was 
approved by a regional notification to the Danish Data Protection Agency, journal number 2008-
58-0028 with local reference-ID 2016-61 (March 31st 2016) and 2018-104 (June 12th 2018).
RESULTS
Within this cohort of 2928 unselected singleton pregnancies, 3.3% had SGA when defined as 
BW≤-22% (Figure 1) and 63% had a selective EFWus. Concerning the entire cohort, the sensitivity 
was 62% given a FPR of 5.6% for SGA defined as BW≤-22%. Performance for SGA defined as 
BW≤-15% is added for comparison (Table 1). For those with mild SGA (BW -22% to -27%), the 
sensitivity of the screening program was 55%; for those with extreme SGA (BW ≤ 33%) it was 
73% (Supporting Information Table S1); whereas it was only 40% (14/35) for newborns delivered 
after 40+0 weeks (Table 2).
For the calculation of these sensitivities, we defined “screen positive” by the last EFWus ≤ -15%.10 
Using an EFWus ≤ -12% would give a sensitivity of 86% at a FPR of 17%; using EFWus ≤ -22%, 
would give a sensitivity 57% at a FPR of 1.6% (Supporting Information Table S2).
The maternal and neonatal characteristics for the SGA and AGA pregnancies are presented in 
Supporting Information Table S3 (SGA) and Table S4 (AGA).
Among the SGA fetuses, we could not demonstrate different perinatal outcome among those 
identified by EFWus and those not identified by EFWus (Table 3) even though the identified SGA 
were more likely to have induction of labor (ORadj = 0.13, 95% CI; 0.04 to 0.41) and elective 
cesarean section (27% vs. 0%, P< 0.01). Among the AGA fetuses, 5.6% were falsely expected 
SGA and these were more likely to have induction of labor (ORadj = 2.51, 95% CI; 1.70 to 3.71) 
and cesarean delivery (ORadj = 1.44, 95% CI; 0.96 to 2.18) (Table 4).
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DISCUSSION
In this study, we investigated the performance of the screening program for SGA defined as BW≤-
22% in the North Denmark Region based on selective EFWus. No less than 63% had an EFWus 
giving a sensitivity of 62%, however much higher for fetuses with extreme SGA. We could not 
demonstrate improved perinatal outcome among SGA fetuses identified by EFWus when compared 
to those not identified by EFWus. The FPR was 5.6% and false positive SGA cases were at an 
increased risk of obstetric interventions.
It is a strength of this study that the cohort can be classified as unselected, as we included more 
than 95% of the pregnant population in a well-defined geographic area13 with a lost to follow-up 
rate of only 5.9%. Furthermore, the validity of the data was very high as it is based on the unique 
Danish personal identification number. It is a limitation that the study is not powered to assess rare 
neonatal outcomes. In addition, referral for EFWus followed the national guidelines. Unfortunately, 
the specific indication for referral is not consistently available in the patient record, and therefore 
the association between SGA and specific indications cannot be evaluated in this study.
In this study, the sensitivity on SGA screening using selective EFWus on clinical indication was 
62%, which is markedly higher than previous studies on selective ultrasound screening reporting a 
sensitivity of 29% to 46%.7,8,14 This could be explained by a larger proportion of women referred 
to EFWus in our study (63%) as compared to prior studies (3.7-42%).7,8,14 The large proportion of 
women referred to EFWus may partly be explained by the inclusion of multiparous women in our 
study (54% of the total cohort). Among multiparous women, indications for EFWus include 
previous obstetric complications such as SGA or preeclampsia, which leads to a higher number of 
referrals.10,15 Moreover, the referral pattern in Aalborg and Denmark might be different than other 
countries.10 Even with such large proportion of all women referred for ultrasound, 21% of SGA 
pregnancies was not referred for EFWus. Moreover, a large proportion of AGA pregnancies (63%) 
underwent EFWus.
We defined a screen positive case in accordance with the national guidelines on SGA screening as 
last EFWus ≤ -15%, ie by a relatively slight estimated weight deviation. Therefore, it is 
disappointing that the sensitivity was only 73% (8/11) for extreme SGA (BW ≤ -33%); two cases A
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did not have an EFWus due to a false negative “clinical screening” based on risk factors and 
symphysis-fundal height measurement; one case had an EFWus >-15% which was performed 29 
days prior to birth (Supporting Information Table S1). Previous publications have not addressed 
this extreme SGA-sensitivity even though these cases are most in need of prenatal detection and 
must be the primary target when we consider potential improvements to our screening program as 
discussed below. It is more acceptable that the sensitivity for mild SGA (BW between -22% and -
27%) was only 55% (29/53) even though they might also benefit from prenatal detection, 
especially when born post term.16 In fact, the EFWus standard deviation of 8% when using The 
Hadlock Formula12 implies that a significant fraction of mild SGA fetuses will remain undetected 
(EFWus >-15%) even when identified by the clinical screening (eg symphysis-fundal height) with 
correct referral for EFWus.
The sensitivity decreased markedly with increasing GA; from 72% (GA 37+0 – 39+6) to 38% (GA 
≥41+0) leaving 22% (21/98) undiagnosed at birth after term (Table 2). Among these, 67% (14/21) 
did not have an EFWus whereas 33% (7/21) had an EFWus > -15%. This is highly problematical, as 
it is generally accepted that SGA babies need to be delivered at least at term.16
We confirmed the results from a Swedish4 study showing increased risk of interventions among 
SGA cased identified correctly before birth (Table 3). However, our study did not have 
statistically power to address their finding of improved neonatal outcome. The FPR is also of 
interest, ie AGA cases falsely expected to be SGA (Table 4), showed an increased rate of labor 
induction (ORadj 2.51, 95% CI; 1.70 to 3.71) and an increased cesarean section rate (ORadj 1.44, 
95% CI; 0.96 to 2.18) confirming results from one prior study.5 
In order to improve the screening for SGA in Denmark, several issues could be considered; 
Selection of pregnancies for EFWus, accuracy of EFWus, and 3rd trimester routine EFWus 
(“universal ultrasound screening”). Improved selection of pregnancies for EFWus might be 
achieved by the use of 1st trimester maternal serum markers17,18 and uterine artery Doppler 
flow19,20, and by improved symphysis-fundal height measurements using a single person 
throughout the pregnancy.21,22 An obvious possibility would be to change the “risk of SGA” 
definition to EFWus ≤ -12% on the expense of a doubled FPR. Furthermore 3D ultrasound23 and 
Magnetic Resonance Imaging24,25 for better estimates of EFW could be considered. Introducing 
routine EFWus (“universal ultrasound screening”) have shown to increase the sensitivity from 29-
33% to 42-80%, but on the expense of increased FPR from 0.26-3% to 5-13% in previous A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
studies.7,14,26,27 Routine EFWus performs best when applied close to delivery26,27; ie a sensitivity of 
89% if delivery was within 2 weeks from routine EFWus in GA 35-37 weeks, at a FPR of 5%.27 As 
suggested by our data, the main limitation of the Danish SGA screening program was in the 
antenatal detection of post term SGA babies. Therefore, introducing a late routine EFWus either at 
term or post term (GA 41+0) would likely increase the sensitivity but also the FPR.
This manuscript focuses on screening for SGA, as small fetal size is regarded a proxy of placental 
dysfunction. However, fetal size is not a perfect marker of placental function, and even a perfect 
screening for SGA may not identify all fetuses at risk because of placental dysfunction.28 New 
markers of placental dysfunction based on maternal serum18 or placental MRI29 may be able to 
identify placental dysfunction directly, and the clinical potential of these methods are currently 
being investigated.
CONCLUSION
The performance of the Danish national screening program for SGA based on selective EFWus on 
clinical indication have improved considerably over the last 20 years with an increased sensitivity 
from 29% (1998) to 62% (2015) and FPR from 0.26% (1998) to 5.6% (2015).8 However, the 
selection of pregnancies for ultrasound is a limitation of the program as a large proportion of AGA 
pregnancies are referred to ultrasound and a large proportion of SGA pregnancies are not. In 
addition, the detection of SGA babies post-term remains rather low when compared to earlier 
gestation. This paper gives a detailed insight in the current screening program, and provides ideas 
for further improvement of SGA screening.
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Supporting Information legends
Table S1: Performance of the screening program for small-for-gestational-age in Denmark in 
relation to birthweight deviation.
Table S2: Screening performance at different ultrasound estimated fetal weight cut-off values.
Table S3: Maternal and neonatal characteristics of small-for-gestational-age-pregnancies.
Table S4: Maternal and neonatal characteristics of appropriate-for-gestational-age-pregnancies.
Figure and table  legends
Figure 1: Flowchart of the study population. SGA, small-for-gestational-age; BW, birthweight; 
EFWus, estimated fetal weight by ultrasound scan; AGA, appropriate-for-gestational-age. SGA is 
defined by BW≤-22% (in accordance with Danish national guidelines) and for comparison by 
BW≤-15%.
Table 1: Performance of the screening program for small for gestational age in Denmark. 
Table 2: Performance of the screening program for small for gestational age in Denmark in 
relation to gestational age at birth.
Table 3: Outcome for small for gestational age -pregnancies.
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Table 4: Outcome for AGA-pregnancies.
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Table 1: Performance of the screening program for small for gestational age in Denmark. 
 
 
 
 
 
 
 
SGA is defined by BW≤-22% (in accordance with Danish 
national guidelines) and for comparison by BW≤-15%. 
SGA, small for gestational age; BW, birthweight; EFWus, estimated fetal weight by ultrasound scan. 
 
 
 
  
Total population, n 2928  
Women never referred to ultrasound 37% (1079/2928) 
Women referred to ultrasound 63%    (1849/2928) 
Time between last ultrasound and birth, 
days (median(interquartile range)) 
11 (2, 28) 
SGA cut-off BW ≤-22% BW≤-15% 
SGA at birth 3.3% (98/2928) 10.3% (303/2928) 
Last EFWus≤-15% 7.5% (219/2928) 7.5% (219/2928) 
Sensitivity (last EFWus≤-15% AND SGA at birth) 62% (61/98) 41.6% (126/303) 
False positive rate 5.6% (158/2830) 3.5% (93/2625) 
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TABLE 2: Performance of the screening program for small for gestational age in Denmark in relation to gestational age at birth. 
 
 
Overall 
Gestational age at birth 
<34 weeks 34
0
-36
6
 weeks 37
0
-39
6
 weeks 40
0
-40
6
 weeks ≥ 41 weeks 
Total population, n 2928  46 130 1,146 845 761 
SGA at birth (BW≤-22%) 3.3% (98/2928) 24% (11/46) 10% (13/130) 3.4% (39/1146) 2.2% (19/845) 2.1% (16/761) 
Sensitivity of screening program 62% (61/98) 73% (8/11) 85% (11/13) 72% (28/39) 42% (8/19) 38% (6/16) 
SGA referred to ultrasound 79% (77/98) 82% (9/11) 92% (12/13) 90% (35/39) 68% (13/19) 50% (8/16) 
Last EFWus ≤ -15% 7.5% (219/2928) 26% (12/46) 15% (20/130) 8.6% (99/1146) 4.7% (40/845) 6.3% (48/761) 
False positive rate 5.6% (158/2830) 11% (4/35) 7.7% (9/117) 6.4% (71/1107) 3.9% (32/826) 5.6% (42/745) 
        
Sensitivity for SGA defined by BW≤-22% using the following cut off; EFWus ≤-15% at last ultrasound scan. 
SGA, small-for-gestational-age; BW, birghtweight; EFWus, estimated fetal weight by ultrasound scan.   
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Table 3: Outcome for small for gestational age -pregnancies. 
Outcome 
SGA 
 
 
OR (95% CI), P-value         Adjusted1 OR (95% CI), P-value 
 
  Total 
 
  n=98 
Expected SGA 
(Last EFWus≤-15%) 
n=61 
Expected AGA 
(Last EFWus>-15% or no EFWus) 
n=37 
Cesarean delivery 36% (35/98) 47% (26/61) 24% (9/37) 0.43 (0.17-1.07), P=0.07 0.71 (0.24-2.13), P=0.54 
Elective cesarean sectio among all cesarean sectio 20% (7/35) 27% (7/26) 0 ** ** 
Intended vaginal delivery 77% (75/98) 72% (44/61) 84% (31/37) 2.31 (0.93-5.72), P=0.07 1.41 (0.47-4.22), P=0.54 
Induction among intended vaginal delivery 57% (44/75) 83% (34/44) 35% (10/31) 0.14 (0.05-0.39), P=0.00* 0.13 (0.04-0.41), P=0.00* 
Vacuum among vaginal delivery  13% (8/63) 17% (6/35) 7.1% (2/28) 0.37 (0.07-2.01), P=0.25 0.41 (0.07-2.30), P=0.31 
Umbilical artery pH <7.1 7.0% (6/86) 7.1% (4/56) 6.7% (2/30) 0.93 (0.16-5.39), P=0.93 0.54 (0.08-3.58), P=0.52 
Apgar score < 7 after 5 minutes 4.2% (4/95) 5.0% (3/60) 2.9% (1/35) 0.56 (0.06-5.59), P=0.62 0.50 (0.04-5.78), P=0.58 
Stillborn 2.0% (2/98) 1.6% (1/61) 2.7% (1/37) 1.67 (0.10-27.47), P=0.72 0.66 (0.02-27.39), P=0.83 
Neonatal death 1.0% (1/98) 1.6% (1/61) 0 ** ** 
Adverse outcome2 11% (11/98) 13% (8/61) 8.1% (3/37) 0.58 (0.14-2.36), P=0.45 0.53 (0.12-2.37), P=0.41 
SGA = BW≤-22%. Expected SGA = EFWus ≤ - 15% at last ultrasound scan. Expected AGA = normal symphysis-fundal-height measurements and/or EFWus > -
15% at last ultrasound scan. Logistic Regression are used to compare the groups of SGA (expected SGA and expected AGA) using SGA-expected SGA as a 
reference. 1. Adjusted for gestational age at birth (weeks in total), birthweight deviation (%), maternal body mass index and parity. 2. Umbilical artery pH<7.1, 
Apgar score <7 after 5 minutes, stillborn and neonatal death in one variable. * P-value < 0.05. ** Logistic regression not possible, because no cases within expected 
AGA-group.  
SGA, small-for-gestational-age; AGA, appropriate-for-gestational-age; EFWus, estimated fetal weight by ultrasound scan; OR, odds ratio; CI, confidence interval.  
 
Table 4: Outcome for appropriate-for-gestational-age-pregnancies. 
Outcome 
AGA 
 
Total 
 
n=2830 
Expected AGA 
(Last EFWus>-15% or no EFWus) 
n=2672 
Expected SGA 
(Last EFWus≤-15%) 
n=158 
OR (95% CI), P-value        Adjusted1 OR (95% CI), P-value 
    
Cesarean delivery 20% (572/2830) 20% (535/2672) 23% (37/158) 1.22 (0.84-1.79), P=0.30 1.44 (0.96-2.18), P=0.08 
Elective cesarean sectio among  
all cesarean sectio 
38% (215/572) 38% (203/535) 32% (12/37) 0.79 (0.39-1.60), P=0.50 1.49 (0.68-3.26), P=0.32 
Intended vaginal delivery 83% (2349/2830) 83% (2221/2672) 81% (128/158) 0.82 (0.56-1.20), P=0.30 0.69 (0.46-1.05), P=0.08 
Induction among intended vaginal delivery 29% (688/2349) 28% (631/2221) 45% (57/128) 2.02 (1.41-2.90), P=0.00* 2.51 (1.70-3.71), P=0.00* 
Vacuum among vaginal delivery  8.3% (187/2258) 8.4% (179/2137) 6.6% (8/121) 0.77 (0.37-1.61), P=0.49 0.66 (0.31-1.44), P=0.30 
Umbilical artery pH <7.1 4.6% (118/2590) 4.6% (113/2443) 3.4% (5/147) 0.73 (0.29-1.81), P=0.49 0.73 (0.28-1.87), P=0.51 
Apgar score < 7 after 5 minutes 0.8% (22/2812) 0.8% (21/2654) 0.6% (1/158) 0.80 (0.11-5.98), P=0.83 0.65 (0.08-5.22), P=0.68 
Stillborn 0.3% (9/2830) 0.3% (9/2672) 0 ** ** 
Neonatal death 0.1% (2/2830) 0.8% (2/2672) 0 ** ** 
Adverse outcome2 5.1% (144/2830) 5.2% (138/2672) 3.8% (6/158) 0.72 (0.31-1.67), P=0.45 0.63 (0.27-1.50), P=0.30 
AGA = BW>-22%. Expected SGA = EFWus ≤ - 15% at last ultrasound scan. Expected AGA = normal symphysis-fundal-height measurements and/or 
EFWus > -15% at last ultrasound scan. Logistic Regression are used to compare the groups of AGA (expected AGA and expected SGA) using AGA-expected AGA 
as a reference 1. Adjusted for gestational age at birth (weeks in total), birthweight deviation (%), maternal body mass index and parity. 2. Umbilical artery pH<7.1, 
Apgar score <7 after 5 minutes, stillborn and neonatal death in one variable. * P-value < 0.05. ** Logistic Regression not possible, because no cases within expected 
SGA-group.  
SGA, small-for-gestational-age; AGA, appropriate-for-gestational-age; EFWus, estimated fetal weight by ultrasound scan;OR, odds ratio; CI, confidence interval. 
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